Management of Etodolac XL-Associated Risks
Patient Risk Assessment
- Patients at high risk for gastrointestinal toxicities include those aged >60 years, with a history of peptic ulcer disease, significant alcohol use, and those on high-dose NSAIDs for long periods, according to the National Comprehensive Cancer Network 1, 2
- Patients at high risk for renal toxicities include those aged >60 years, with compromised fluid status, interstitial nephritis, and concomitant administration of other nephrotoxic drugs, as recommended by the National Comprehensive Cancer Network 1, 2
- Patients at high risk for cardiac toxicities include those with a history of cardiovascular disease or at risk for cardiovascular disease or complications, as suggested by the National Comprehensive Cancer Network 1, 2
Monitoring and Prevention
- Consider baseline and periodic (every 3 months) CBC and fecal occult blood testing to monitor for gastrointestinal bleeding, as recommended by the National Comprehensive Cancer Network 1, 3
- Obtain baseline and periodic (every 3 months) blood pressure, BUN, and creatinine measurements to monitor for renal toxicities, according to the National Comprehensive Cancer Network 1, 3
- Monitor blood pressure regularly to assess cardiovascular risk, as suggested by the National Comprehensive Cancer Network 1, 3
- Consider proton pump inhibitor or misoprostol for gastrointestinal protection in older patients, as recommended by the American Geriatrics Society and the Clinical Gastroenterology and Hepatology journal 4, 5
Special Considerations
- Etodolac may increase bleeding risk when taken with prescribed anticoagulants such as warfarin or heparin, as warned by the National Comprehensive Cancer Network 1, 2
- Avoid concurrent use with other NSAIDs, including aspirin, to prevent excess toxicity, as advised by the American Geriatrics Society and the Clinical Gastroenterology and Hepatology journal 4, 5
- Consider temporary discontinuation of etodolac during acute illness with vomiting, diarrhea, or significant fluid losses, as recommended by the American Journal of Kidney Diseases 7
Alternative Therapy
- If two NSAIDs are tried in succession without efficacy, consider another approach to analgesia, as suggested by the National Comprehensive Cancer Network 1, 2
- For patients with cancer pain, opioid analgesics are safe and effective alternative analgesics to NSAIDs, according to the National Comprehensive Cancer Network 1, 3
- For patients with neuropathic pain, consider medications specifically indicated for this condition, as recommended by the Mayo Clinic Proceedings 8